Tomoki Makino

Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

Yuichiro� Doki, Jaffer A. Ajani, Ken Kato et al. · UCL Discovery (University College London) · 2022 · 532 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1

Yuko Kitagawa, Ryu Ishihara, Hitoshi Ishikawa et al. · Esophagus · 2023 · 391 citations · Full text

Medicine, Health Policy, Oncology +11

Esophageal cancer practice guidelines 2022 edited by the Japan Esophageal Society: part 2

Yuko Kitagawa, Ryu Ishihara, Hitoshi Ishikawa et al. · Esophagus · 2023 · 188 citations · Full text

Medicine, Oncology, Surgery +16

Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma

Hisashi Hara, Tsuyoshi Takahashi, Satoshi Serada et al. · British Journal of Cancer · 2016 · 135 citations · Full text

Medicine, Cancer Biology, Oncology +17

Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma

Makoto Yamasaki, Tomoki Makino, Toshimitsu Masuzawa et al. · British Journal of Cancer · 2011 · 132 citations · Full text

Medicine, Oncology, Pharmacology +15